These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 22462146)

  • 1. [Kidney diseases and mineralocorticoid receptor].
    Nagase M
    Nihon Naika Gakkai Zasshi; 2009 Nov; 98(11):2894-902. PubMed ID: 22462146
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chronic kidney disease and the aldosterone/mineralocorticoid receptor system].
    Nagase M; Fujita T
    Nihon Jinzo Gakkai Shi; 2010; 52(2):125-31. PubMed ID: 20415233
    [No Abstract]   [Full Text] [Related]  

  • 3. Mineralocorticoid receptor activation and mineralocorticoid receptor antagonist treatment in cardiac and renal diseases.
    Bauersachs J; Jaisser F; Toto R
    Hypertension; 2015 Feb; 65(2):257-63. PubMed ID: 25368026
    [No Abstract]   [Full Text] [Related]  

  • 4. [Roll of aldosterone in pathogenesis of kidney disorders].
    Kitamura K; Tomita K
    Nihon Naika Gakkai Zasshi; 2005 Jul; 94(7):1428-34. PubMed ID: 16097603
    [No Abstract]   [Full Text] [Related]  

  • 5. Aldosterone in vascular and metabolic dysfunction.
    Luther JM
    Curr Opin Nephrol Hypertens; 2016 Jan; 25(1):16-21. PubMed ID: 26575396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Aldosterone and kidney diseases: an emergent paradigm with important clinical implications].
    Bertocchio JP; Jaisser F
    Nephrol Ther; 2011 Jun; 7(3):139-47. PubMed ID: 21144811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mineralocorticoid receptor activation and blockade: an emerging paradigm in chronic kidney disease.
    Bertocchio JP; Warnock DG; Jaisser F
    Kidney Int; 2011 May; 79(10):1051-60. PubMed ID: 21412221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Participation of the mineralocorticoid receptor in cardiac and vascular remodeling.
    Fiebeler A; Haller H
    Nephron Physiol; 2003; 94(3):p47-50. PubMed ID: 12902615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Mineralocorticoid Receptors in Obstructive Sleep Apnea and Metabolic Syndrome.
    Valaiyapathi B; Calhoun DA
    Curr Hypertens Rep; 2018 Mar; 20(3):23. PubMed ID: 29556729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mineralocorticoid receptor activation and oxidative stress.
    Funder JW
    Hypertension; 2007 Nov; 50(5):840-1. PubMed ID: 17923584
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mineralocorticoid receptor: an update].
    Nagase M
    Nihon Rinsho; 2012 Sep; 70(9):1504-9. PubMed ID: 23012795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nongenomic actions of aldosterone.
    Funder JW
    Endocr Rev; 2005 May; 26(3):313-21. PubMed ID: 15814845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of aldosterone and mineralocorticoid receptors in cardiovascular disease.
    Funder JW
    Am J Cardiovasc Drugs; 2007; 7(3):151-7. PubMed ID: 17610342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldosterone in clinical nephrology--old hormone, new questions.
    Becker GJ; Hewitson TD; Chrysostomou A
    Nephrol Dial Transplant; 2009 Aug; 24(8):2316-21. PubMed ID: 19494367
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cardioprotective effect of aldosterone antagonists for ventricular remodeling].
    Tatsumi T; Matsubara H
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():524-9. PubMed ID: 16897886
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular and cellular determinants of mineralocorticoid selectivity.
    Farman N
    Curr Opin Nephrol Hypertens; 1999 Jan; 8(1):45-51. PubMed ID: 9914860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Novel evidence for sodium sensitivity and renal impairment].
    Andoh D; Yasuda G; Umemura S
    Nihon Jinzo Gakkai Shi; 2009; 51(4):428-32. PubMed ID: 19601547
    [No Abstract]   [Full Text] [Related]  

  • 18. Non-genomic actions of aldosterone: mechanisms and consequences in kidney cells.
    Boldyreff B; Wehling M
    Nephrol Dial Transplant; 2003 Sep; 18(9):1693-5. PubMed ID: 12937210
    [No Abstract]   [Full Text] [Related]  

  • 19. A new look at the eye: aldosterone and mineralocorticoid receptors as novel targets in retinal vasculopathy.
    Touyz RM; Callera GE
    Circ Res; 2009 Jan; 104(1):9-11. PubMed ID: 19118282
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular effects of aldosterone.
    Murin J
    Bratisl Lek Listy; 2005; 106(1):3-19. PubMed ID: 15869008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.